RELATED CONTENT
NEWS
- Formal Japanese approvals include first nod worldwide for teneligliptin
- LigoCyte acquisition gives Takeda norovirus vaccine lead
- Serum's Bilthoven acquisition opens door to cut-price polio vaccine in Europe and US
- Flu vaccine 62% effective for US season; some 'spot' shortages
COMMENT
Other Informa Comment

